Unknown PHASE3 INTERVENTIONAL 2-arm NCT04221672

The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy

Study on the Effect of Terlipressin on Recovery of Liver Function After Hepatectomy: a Multicenter Randomized Controlled Study

Sponsor: Shanghai Zhongshan Hospital

Conditions Acute Kidney Injury Ascites Hepatic Liver Failure Terlipressin Adverse Reaction

Interventions Standard care Terlipressin plus standard care

Updated 5 times since 2020 Last updated: Jan 7, 2020 Started: Nov 7, 2019 Primary completion: Dec 30, 2020 Completion: Dec 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Acute Kidney Injury and Ascites Hepatic and is currently ongoing. Shanghai Zhongshan Hospital leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2022 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jan 2021 — Jan 2022 [monthly]

Recruiting PHASE3
Feb 2020 — Jan 2021 [monthly]

Recruiting PHASE3

First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Zhongshan Hospital

Data source: Shanghai Zhongshan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China